Tuberculosis is a disease caused by a bacterium called Mycobacterium tuberculosis which usually attack the lungs, but can attack any part of the body such as the kidney, spine, and brain.
Cananda contributes 4% of the TB donor funds towards TB treatment and awareness program world wide. Canada has <4 mortality rate of TB per 100000 of population.
Tuberculosis prevention and control efforts primarily rely on the vaccination of infants and the detection and appropriate treatment of active cases. The only available vaccine as of 2011 is Bacillus Calmette-Guérin (BCG)
The BCG vaccine has limitations, and research to develop new TB vaccines is ongoing. A number of potential candidates are currently in phase I and II clinical trials